We recently described 5 unrelated children with autoimmune lymphoproliferative syndrome (ALPS) whom had dominant interfering mutations in Fas, a transmembrane protein of the tumor necrosis receptor family that mediates apoptosis of lymphoid cells. All 5 children with ALPS had heterozygous mutations in Fas; 4 of the mutant Fas molecules were shown to dominantly interfere with the induction of apoptosis by wild type Fas. The 5 children had massive non-mailgnant lymphadenopathy, autoimmune thrombocytopenia, hemolytic anemia, hyper-gammaglobulinemia as well as significant expansion of an unsusual subset of T cells that express T-cell receptors but neither CD4 nor CD8 (CD4-/CD8-). As seen in MRL/lpr mice, which also have autoimmune phenotype and elevated CD4-/CD8- T-cells, our patients demonstrated defective programmed cell death in response to Fas stimulation. A sixth ALPS patient has now been studied and found not to have a mutation in either allele of the Fas gene. Clinically this patient is indistinguishable from the previously characterized ALPS patients and like them has defective Fas-mediated apoptosis, in-vitro. Furthermore this patient's parents have normal Fas mediated apoptosis. The pattern of inheritance and our molecular charactreization of this ALPS patient are consistent with a recessive defect in an intracellular signalling molecule of the Fas apoptotic pathway and that both parents are carriers for this mutation.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Fisher, G., Wong, J., Kim, P. et al. Defective FAS Mediated Apoptosis in a Human Autoimmune Lymphoproliferative Syndrome. • 46. Pediatr Res 39 (Suppl 4), 10 (1996). https://doi.org/10.1203/00006450-199604001-00065
Issue Date:
DOI: https://doi.org/10.1203/00006450-199604001-00065